AsiaMedic Limited (SGX:505)
Singapore
· Delayed Price · Currency is SGD 0.0100
-0.0010 (-9.09%)
At close: Mar 27, 2025
AsiaMedic Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 1.01 | 1.92 | 2.19 | 0.72 | -4.3 | Upgrade
|
| Depreciation & Amortization | 2.47 | 2.07 | 1.05 | 1.27 | 2.66 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.07 | -0.12 | -0.95 | 0.86 | 4.19 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.32 | -0.44 | -0.48 | -0.36 | -0.37 | Upgrade
|
| Stock-Based Compensation | 0.02 | 0.01 | - | - | -0 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | - | 0.02 | - | - | Upgrade
|
| Other Operating Activities | 0.33 | -0.61 | 0.2 | 0.32 | -0.28 | Upgrade
|
| Change in Accounts Receivable | -1.8 | 0.09 | -0.86 | 0.29 | 0.49 | Upgrade
|
| Change in Inventory | 0.05 | -0.1 | -0.01 | 0.02 | 0 | Upgrade
|
| Change in Accounts Payable | 0.99 | 0.73 | 0.26 | 0.5 | -0.15 | Upgrade
|
| Change in Unearned Revenue | -0.22 | -0.13 | -0.19 | -0.18 | 0.09 | Upgrade
|
| Operating Cash Flow | 2.48 | 3.41 | 1.23 | 3.44 | 2.33 | Upgrade
|
| Operating Cash Flow Growth | -27.32% | 176.73% | -64.11% | 47.38% | 2481.23% | Upgrade
|
| Capital Expenditures | -1.81 | -2.43 | -1 | -0.38 | -0.35 | Upgrade
|
| Investment in Securities | 1.49 | -2.99 | -1.98 | - | - | Upgrade
|
| Other Investing Activities | 0.53 | 0.56 | 0.33 | 0.32 | 0.49 | Upgrade
|
| Investing Cash Flow | 0.21 | -4.86 | -2.65 | -0.06 | 0.14 | Upgrade
|
| Long-Term Debt Issued | - | 0.61 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -1.81 | -1.13 | -1.08 | -1.42 | -1.08 | Upgrade
|
| Net Debt Issued (Repaid) | -1.81 | -0.52 | -1.08 | -1.42 | -1.08 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 3.52 | Upgrade
|
| Other Financing Activities | 2.5 | -0.07 | -0.33 | -0.14 | -0.16 | Upgrade
|
| Financing Cash Flow | 0.69 | -0.59 | -1.41 | -1.56 | 2.29 | Upgrade
|
| Net Cash Flow | 3.39 | -2.04 | -2.83 | 1.82 | 4.77 | Upgrade
|
| Free Cash Flow | 0.68 | 0.98 | 0.23 | 3.06 | 1.98 | Upgrade
|
| Free Cash Flow Growth | -31.31% | 319.99% | -92.34% | 54.27% | - | Upgrade
|
| Free Cash Flow Margin | 2.32% | 4.14% | 1.23% | 16.60% | 12.89% | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | Upgrade
|
| Cash Interest Paid | 0.59 | 0.42 | 0.24 | 0.14 | 0.19 | Upgrade
|
| Levered Free Cash Flow | 1.06 | 0.92 | -0.38 | 1.25 | 1.26 | Upgrade
|
| Unlevered Free Cash Flow | 1.41 | 1.19 | -0.23 | 1.34 | 1.38 | Upgrade
|
| Change in Net Working Capital | -0.32 | -1.09 | 0.85 | 0.04 | -0.41 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.